Status: Recruiting
Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN)
The purpose of this study is to assess the feasibility and safety of the Transverse Medical, Inc. Point-Guard device. This feasibility study is a limited clinical investigation of the Point-Guard device. The study will be conducted to evaluate the device design concept with respect to clinical safety and device functionality.
Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Transverse Medical, Inc.Updated: May 8, 2025Locations: 1
Eligibility criteria
The patient is ≥18 years of age; [+3]
TAVR conducted via other than transfemoral access (subclavian, axillar, transapi... [+15]